Lactalis buys Saputo’s British dairy unit for $1.34 billion

• The acquisition positions Lactalis as a leader in the British cheddar, butter, and margarine markets
• Saputo's Britain unit employs 1,300 people and generates 94% of its sales revenues in Britain
• Key brands included in the deal are Cathedral City and Davidstow cheddar, Wensleydale Creamery cheese, Country Life butter, and Clover and Utterly Butterly margarines

Lactalis Acquires Saputo's British Dairy Business for $1.34 Billion

French dairy giant Lactalis has agreed to acquire Canadian competitor Saputo's British operations for £988 million ($1.34 billion), announced Friday, August 14.

Key Transaction Details:

• The acquisition positions Lactalis as a market leader in British cheddar, butter, and margarine segments
• Saputo's UK unit employs 1,300 people and generates 94% of its sales revenue in Britain

Assets and Brands Included:

The deal encompasses several prominent British dairy brands:

• Cathedral City and Davistow (cheddar cheese)
• Wensleydale Creamery (cheese)
• Country Life (butter)
• Clover and Utterly Butterly (margarine brands)

Market Implications:

This transaction represents significant consolidation in the UK dairy sector, with Lactalis expanding its footprint in one of Europe's largest dairy markets. The acquisition strengthens Lactalis's position against competitors in premium and everyday dairy categories, particularly in the strategically important cheddar and butter segments.

For Saputo, the divestiture of its British operations suggests a potential strategic realignment or focus on other geographic markets. The $1.34 billion valuation indicates strong market value for established dairy brands with dominant market positions.

The deal comes at a time when European dairy companies are seeking scale advantages amid rising production costs and changing consumer preferences. Lactalis, already one of the world's largest dairy companies, continues its growth-through-acquisition strategy to dominate regional markets.

The transaction is subject to standard regulatory approvals, though no completion date was specified in the announcement.